Change in cognitive function in idiopathic Parkinson disease

Archives of Neurology

Volumn 53, Issue 11, 1996, Pages 1140-1146

  Bayles, Kathryn A ^a,b   Tomoeda, Cheryl K ^a   Wood, Jody A ^a   Montgomery Jr , Erwin B ^a   Cruz, Robyn F ^a   Azuma, Tamiko ^a   McGeagh, Anna ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PRIORITY JOURNAL; PSYCHOMETRY; RATING SCALE;

EID: 0029817556     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1996.00550110080015     Document Type: Article

References (44)

1. Fischer P, Gatterer G, Simanyi M, et al. Memory deficits in advanced Parkinson's disease. J Neural Transm. 1990;2:59-70.
2. Bowen FP, Hoehn MM, Yahr MD. Parkinsonism: alterations in spatial orientation as determined by a route-walking test. Neuropsychologia. 1972;10:355-361.
3. El Awar M, Becker JT, Hammond KM, Nebes RD, Boiler F. Learning deficits in Parkinson's disease: comparison with Alzheimer's disease and normal aging. Arch Neurol. 1987;44:180-184.
4. Huber SJ, Shulman HG, Paulson GW, Shuttleworth EC. Fluctuations in plasma dopamine level impair memory in Parkinson's disease. Neurology, 1987;37: 1371-1375.
5. Danielczyk W, Fischer P. Parkinson's disease: development of dementia in aging. In: Przuntek H, Riederer P, eds. Early Diagnosis and Preventive Therapy in Parkinson's Disease. New York, NY: Springer Publishing Co Inc; 1989:9-17.
6. Stern Y, Richards M, Sano M, Mayeux R. Comparison of cognitive changes in patients with Alzheimer's and Parkinson's disease. Arch Neurol. 1993;50:1040-1045.
7. Martilla RJ, Rinne UK. Dementia in Parkinson's disease. Acta Neurol Scand. 1976;54:431-441.
8. Reitan RM, Boll TJ. Intellectual and cognitive functions in Parkinson's disease. J Consult Clin Psychol. 1971;37:364-369.
9. Pirozzolo FJ. Hansch EC, Mortimer JA, Webster DD, Kuskowski MA. Dementia in Parkinson's disease: a neuropsychological analysis. Brain Cogn. 1982;1:71-83.
10. Taylor A, Saint-Cyr JA, Lang AE. Dementia prevalence in Parkinson's disease. Lancet. 1985;1:1037.
11. Stern Y, Mayeux R. Intellectual impairments in Parkinson's disease. Adv Neurol. 1985;45:405-407.
12. Portin R, Rinne UK. Neuropsychological responses of parkinsonian patients to long-term levodopa treatment. In: Rinne UK, Klingler M, Stamm G, eds. Parkinson's Disease: Current Progress, Problems, and Management. Amsterdam, the Netherlands: Elsevier Science Publishers; 1980:271-304.
13. Mortimer JA, Jun S-P, Kuskowski MA, Webster DD, Subtypes of Parkinson's disease defined by intellectual impairment. In: Wurtman RJ, Corkin S, Growdon JH, eds. Topics in the Basic and Clinical Science of Dementia: Proceedings of the Fourth Zurich Meeting of the International Study Group on the Pharmacology of Memory Disorders Associated With Aging. Vienna, Austria: Springer Publishing Co Inc; 1987;101-104.
14. Growdon J, Corkin S. Cognitive impairments in Parkinson's disease. Adv Neurol. 1986;45:383-391.
15. Portin R, Rinne UK. Predictive factors for cognitive deterioration and dementia in Parkinson's disease. Adv Neurol. 1986;45:413-416.
16. Starkstein S, Mayberg H, Leiguarda R, Preziosi T, Robinson R. A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry. 1992;55: 377-382.
17. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
18. Wing JK, Cooper JE, Sartorius N. Measurements and Classification of Psychiatric Symptoms. New York, NY: Cambridge University Press; 1974.
19. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23:56-62.
20. Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Psychol. 1967;6:278-296.
21. Mitrushina M, Satz P. Reliability and validity of the Mini-Mental State Exam in neurologically intact elderly. J Clin Psychol. 1991;47:537-543.
22. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A. Pathological verification of ischemic scores in differentiation of dementia. Arch Neurol. 1980;32:632-637.
23. Wilson R, Rosenbaum G, Brown G, Rourke D, Whitman D. An index of premorbid intelligence. J Consult Clin Psychol. 1978;46:1554-1555.
24. Lazarus LW, Newton N, Cohler B, Lesser J, Schweon C. Frequency and presentation of depressive symptoms in patients with primary degenerative dementia. Am J Psychiatry. 1987;144:41-45.
25. Fahn S, Elton R, Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden D, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease. Florham Park, NY: McMillan Health Care Information; 1987;2:153-163.
26. Hoehn M, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology. 1967;17:427-442.
27. Schwab RS, England AC Jr. Projection technique for evaluating surgery in Parkinson's disease. In: Gillingham FJ, Donaldson IML, eds. Third Symposium on Parkinson's Disease. Edinburgh, Scotland: E & S Livingstone; 1969:152-157.
28. National Institute of Mental Health. The Diagnostic Interview Schedule. Washington, DC: NIMH Center for Epidemiological Studies; 1979.
29. Tombaugh T, McIntyre N. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc. 1992;40:922-935.
30. Olin JT, Zelinski EM. The 12-month reliability of the Mini-Mental State Examination. Psychol Assess. 1991;3:427-432.
31. Morris JC, Heyman A, Mohs RC, et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD), I: clinical and neuropsychological assessment of Alzheimer's disease. Neurology. 1989;39:1159-1165.
32. Becker JT, Huff J, Nebes RD, Holland A, Boller F. Neuropsychological function in Alzheimer's disease: pattern of impairment and rates of progression. Arch Neural. 1988;45:263-268.
33. Lopez OL, Swihart AA, Becker JT, et al. Reliability and validity of NINCDS-ADRDA clinical criteria for the diagnosis of Alzheimer's disease. Neurology. 1990;40:1517-1522.
34. O'Connor DW, Pollitt PA, Hyde JL, Fellows ND, Roth M. A follow-up study of dementia diagnosed in the community using the Cambridge Mental Disorders of the Elderly Examination. Acta Psychiatr Scand. 1989;81:78-82.
35. Anastasi A. Psychological Testing. 6th ed. New York, NY: Macmillan Publishing Co Inc; 1988.
36. Langtry HD, Clissold SP. Pergolide: a review of its pharmacological properties and therapeutic potential in Parkinson's disease. Drugs. 1990;39:491-506.
37. Koller WC, Silver DE, Lieberman A. An algorithm for the management of Parkinson's disease. Neurology. 1994;44(suppl 10):S1-S54.
38. Pillon B, Oubois B, Ploska A, Agid Y. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy. Neurology. 1991;41:634-643.
39. Mayeux R, Stern Y, Rosenstein R, et al. An estimate of the prevalence of dementia in idiopathic Parkinson's disease. Arch Neurol. 1988;45:260-262.
40. Biggins CA, Boyd JL, Harrop FM, et al. A controlled, longitudinal study of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1992;55:566-571.
41. Lieberman A, Dziatolowski M, Kupersmith M, et al. Dementia in Parkinson's disease. Ann Neurol. 1979;6:355-359.
42. Celesia GG, Wanamaker WM. Psychiatric disturbances in Parkinson's disease. Dis Nerv Syst. 1972;33:577-583.
43. Garron DC, Klawans HL Jr, Narin F. Intellectual functioning of persons with idiopathic parkinsonism. J Nerv Ment Dis. 1972;154:445-452.
44. Mortimer J, Pirozzolo F, Hansen E, Webster D. Relationship of motor symptoms to intellectual deficits in Parkinson's disease. Neurology. 1982;32:133-137.